Article Text
Meeting report
Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology
Abstract
A working report from the OMERACT Health Economics Group. The group is working towards creating common standards for economic evaluation in rheumatology and also towards improving the scientific underpinning of economic evaluation, particularly pertaining to the rheumatic diseases. Preliminary recommendations for “reference cases” in osteoporosis, rheumatoid arthritis, and osteoarthritis are proposed.
- OMERACT Economics Working Group
- economic evaluation
- rheumatology
- NSAID, non-steroidal anti-inflammatory drug
- OA, osteoarthritis
- RA, rheumatoid arthritis